Paper39635532
The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.
Rehman R and 7 others. Front Immunol, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI. Papers, record 39635532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39635532
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Microglia | Major topic |
| Brain Injuries, Traumatic | Major topic |
| Animals | |
| Mice | |
| Male | |
| Synapses | |
| Mice, Inbred C57BL | |
| Phosphorylation | |
| Disease Models, Animal | |
| Receptor, Fibroblast Growth Factor, Type 1 | |
| Protein Kinase Inhibitors |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32615087 | Microglial Remodeling of the Extracellular Matrix Promotes Synapse Plasticity. | Cell | 2020 | https://conductscience.org/library/papers/32615087 | PubMed |
| 2 | 37757826 | Clinical development and management of adverse events associated with FGFR inhibitors. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/37757826 | PubMed |
| 3 | 33860438 | Fibroblast Growth Factor Signalling in the Diseased Nervous System. | Mol Neurobiol | 2021 | https://conductscience.org/library/papers/33860438 | PubMed |
| 4 | 34226493 | ErbB4 promotes inhibitory synapse formation by cell adhesion, independent of its kinase activity. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/34226493 | PubMed |
| 5 | 36403719 | Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update. | Pharmacol Res | 2023 | https://conductscience.org/library/papers/36403719 | PubMed |
| 6 | 36738678 | An insight into the TAM system in Alzheimer's disease. | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/36738678 | PubMed |
| 7 | 38447109 | Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits. | PLoS Biol | 2024 | https://conductscience.org/library/papers/38447109 | PubMed |
| 8 | 29774782 | The Neuroprotective Effect of Ethanol Intoxication in Traumatic Brain Injury Is Associated with the Suppression of ErbB Signaling in Parvalbumin-Positive Interneurons. | J Neurotrauma | 2018 | https://conductscience.org/library/papers/29774782 | PubMed |
| 9 | 36423280 | Cortical wiring by synapse type-specific control of local protein synthesis. | Science | 2022 | https://conductscience.org/library/papers/36423280 | PubMed |
| 10 | 25913734 | Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions. | Glia | 2015 | https://conductscience.org/library/papers/25913734 | PubMed |
| 11 | 30535946 | The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments. | Acta Neuropathol | 2019 | https://conductscience.org/library/papers/30535946 | PubMed |
| 12 | 32142677 | Repopulating Microglia Promote Brain Repair in an IL-6-Dependent Manner. | Cell | 2020 | https://conductscience.org/library/papers/32142677 | PubMed |
| 13 | 37400950 | The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti-inflammatory effects and remyelination in a model of multiple sclerosis. | Br J Pharmacol | 2023 | https://conductscience.org/library/papers/37400950 | PubMed |
| 14 | 36403069 | Neuronal nuclear calcium signaling suppression of microglial reactivity is mediated by osteoprotegerin after traumatic brain injury. | J Neuroinflammation | 2022 | https://conductscience.org/library/papers/36403069 | PubMed |
| 15 | 29735556 | USP8 Deubiquitinates SHANK3 to Control Synapse Density and SHANK3 Activity-Dependent Protein Levels. | J Neurosci | 2018 | https://conductscience.org/library/papers/29735556 | PubMed |
| 16 | 12405992 | Fibroblast growth factor-2 increases functional excitatory synapses on hippocampal neurons. | Eur J Neurosci | 2002 | https://conductscience.org/library/papers/12405992 | PubMed |
| 17 | 36577378 | Met/HGFR triggers detrimental reactive microglia in TBI. | Cell Rep | 2022 | https://conductscience.org/library/papers/36577378 | PubMed |
| 18 | 36888713 | Brain injury accelerates the onset of a reversible age-related microglial phenotype associated with inflammatory neurodegeneration. | Sci Adv | 2023 | https://conductscience.org/library/papers/36888713 | PubMed |
| 19 | 38825349 | Dynamics of synaptic damage in severe traumatic brain injury revealed by cerebrospinal fluid SNAP-25 and VILIP-1. | J Neurol Neurosurg Psychiatry | 2024 | https://conductscience.org/library/papers/38825349 | PubMed |
| 20 | 36099710 | Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study. | Lung Cancer | 2022 | https://conductscience.org/library/papers/36099710 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42650835 | Electroacupuncture Prevents TBI-Induced Synaptic Loss by Inhibiting CaMKII/Drp1-Dependent Mitochondrial Fission. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650835 | PubMed |
| 41469684 | Astrocytic SIRT1 ameliorates cognitive deficits after traumatic brain injury via autophagy-mediated MEGF10 phagocytosis. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/41469684 | PubMed |
| 40538537 | Erdafitinib diminishes LPS-mediated neuroinflammatory responses through NLRP3 in wild-type mice. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40538537 | PubMed |
| 40518115 | FGFs/FGFRs and neuroinflammatory diseases: mechanism, drug therapies and delivery systems. | J Adv Res | 2025 | https://conductscience.org/library/papers/40518115 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39635532
GET https://conductscience.org/api/papers/v1/39635532/references?page=2